Abstract
To evaluate dog owners' opinions regarding the use of psychoactive medications and alternatives in dogs, 513 past or present dog owners completed an online, anonymous survey. Owners reported their comfort levels, concerns, and relevant decision factors regarding the use of psychoactive medications (divided into categories of fast-acting/situational and slow-acting/daily medications), herbal or nutritional supplements, pheromonal products, and cannabinoid products for their dogs. Data were analyzed using descriptive statistics and nonparametric correlation analysis. Dog owners were more comfortable overall with the use of fast-acting versus slow-acting medications (62.3% [N = 320] and 42.7% [N = 219] were comfortable, respectively). The most concerning undesirable effects for owners were sedation, potential for addiction, and changing their dog's personality in a negative way. Most dog owners (90.3%, N = 463) considered proven effectiveness to be an important consideration factor when considering psychoactive medication or alternative use for their dogs, followed by ease of administration (79.9%, N = 410), veterinarian recommendation (77.4%, N = 397), and cost (76.6%, N = 393). Owners who had a personal history of taking psychoactive medications for anxiety or depression expressed higher comfort levels giving their dogs fast-acting medications, slow-acting medications, pheromonal products, and cannabinoids than owners who had not taken these products. The information gathered in this study will help veterinarians understand their clients' attitudes toward psychoactive medications and alternatives and be prepared to address owners' questions and concerns.
| Original language | English (US) |
|---|---|
| Journal | Journal of Veterinary Behavior |
| DOIs | |
| State | Accepted/In press - Jan 1 2020 |
Fingerprint
Keywords
- canine anxiety
- cannabinoid
- herbal supplement
- nutritional supplement
- pheromone
- psychoactive/psychotropic medications
ASJC Scopus subject areas
- veterinary(all)
Cite this
A survey of dog owners’ perceptions on the use of psychoactive medications and alternatives for the treatment of canine behavior problems. / van Haaften, Karen A.; Grigg, Emma K.; Kolus, Cheryl; Hart, Lynette; Kogan, Lori R.
In: Journal of Veterinary Behavior, 01.01.2020.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A survey of dog owners’ perceptions on the use of psychoactive medications and alternatives for the treatment of canine behavior problems
AU - van Haaften, Karen A.
AU - Grigg, Emma K.
AU - Kolus, Cheryl
AU - Hart, Lynette
AU - Kogan, Lori R.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - To evaluate dog owners' opinions regarding the use of psychoactive medications and alternatives in dogs, 513 past or present dog owners completed an online, anonymous survey. Owners reported their comfort levels, concerns, and relevant decision factors regarding the use of psychoactive medications (divided into categories of fast-acting/situational and slow-acting/daily medications), herbal or nutritional supplements, pheromonal products, and cannabinoid products for their dogs. Data were analyzed using descriptive statistics and nonparametric correlation analysis. Dog owners were more comfortable overall with the use of fast-acting versus slow-acting medications (62.3% [N = 320] and 42.7% [N = 219] were comfortable, respectively). The most concerning undesirable effects for owners were sedation, potential for addiction, and changing their dog's personality in a negative way. Most dog owners (90.3%, N = 463) considered proven effectiveness to be an important consideration factor when considering psychoactive medication or alternative use for their dogs, followed by ease of administration (79.9%, N = 410), veterinarian recommendation (77.4%, N = 397), and cost (76.6%, N = 393). Owners who had a personal history of taking psychoactive medications for anxiety or depression expressed higher comfort levels giving their dogs fast-acting medications, slow-acting medications, pheromonal products, and cannabinoids than owners who had not taken these products. The information gathered in this study will help veterinarians understand their clients' attitudes toward psychoactive medications and alternatives and be prepared to address owners' questions and concerns.
AB - To evaluate dog owners' opinions regarding the use of psychoactive medications and alternatives in dogs, 513 past or present dog owners completed an online, anonymous survey. Owners reported their comfort levels, concerns, and relevant decision factors regarding the use of psychoactive medications (divided into categories of fast-acting/situational and slow-acting/daily medications), herbal or nutritional supplements, pheromonal products, and cannabinoid products for their dogs. Data were analyzed using descriptive statistics and nonparametric correlation analysis. Dog owners were more comfortable overall with the use of fast-acting versus slow-acting medications (62.3% [N = 320] and 42.7% [N = 219] were comfortable, respectively). The most concerning undesirable effects for owners were sedation, potential for addiction, and changing their dog's personality in a negative way. Most dog owners (90.3%, N = 463) considered proven effectiveness to be an important consideration factor when considering psychoactive medication or alternative use for their dogs, followed by ease of administration (79.9%, N = 410), veterinarian recommendation (77.4%, N = 397), and cost (76.6%, N = 393). Owners who had a personal history of taking psychoactive medications for anxiety or depression expressed higher comfort levels giving their dogs fast-acting medications, slow-acting medications, pheromonal products, and cannabinoids than owners who had not taken these products. The information gathered in this study will help veterinarians understand their clients' attitudes toward psychoactive medications and alternatives and be prepared to address owners' questions and concerns.
KW - canine anxiety
KW - cannabinoid
KW - herbal supplement
KW - nutritional supplement
KW - pheromone
KW - psychoactive/psychotropic medications
UR - http://www.scopus.com/inward/record.url?scp=85077926984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077926984&partnerID=8YFLogxK
U2 - 10.1016/j.jveb.2019.10.002
DO - 10.1016/j.jveb.2019.10.002
M3 - Article
AN - SCOPUS:85077926984
JO - Journal of Veterinary Behavior: Clinical Applications and Research
JF - Journal of Veterinary Behavior: Clinical Applications and Research
SN - 1558-7878
ER -